CAD 0.05
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 25.61 Million CAD | -5.41% |
2022 | 27.07 Million CAD | -11.84% |
2021 | 30.71 Million CAD | 279646.19% |
2020 | 10.98 Thousand CAD | 323.28% |
2019 | 2594.00 CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 24.84 Million CAD | -1.52% |
2024 Q1 | 25.23 Million CAD | -1.49% |
2023 Q3 | 23.82 Million CAD | -2.31% |
2023 FY | 25.61 Million CAD | -5.41% |
2023 Q4 | 25.61 Million CAD | 7.51% |
2023 Q2 | 24.38 Million CAD | -5.23% |
2023 Q1 | 25.73 Million CAD | -4.97% |
2022 Q1 | 29.57 Million CAD | -3.71% |
2022 Q3 | 28.27 Million CAD | -0.85% |
2022 Q2 | 28.51 Million CAD | -3.59% |
2022 FY | 27.07 Million CAD | -11.84% |
2022 Q4 | 27.07 Million CAD | -4.22% |
2021 FY | 30.71 Million CAD | 279646.19% |
2021 Q4 | 30.71 Million CAD | 1162.45% |
2021 Q3 | 2.43 Million CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | 4.19 Million CAD | -510.742% |
BetterLife Pharma Inc. | 324.74 Thousand CAD | -7786.99% |
BioVaxys Technology Corp. | 113.47 Thousand CAD | -22470.618% |
ChitogenX Inc. | 534 Thousand CAD | -4696.383% |
Rapid Dose Therapeutics Corp. | 1.88 Million CAD | -1258.646% |
Defence Therapeutics Inc. | 477.74 Thousand CAD | -5261.14% |
Entheon Biomedical Corp. | 401.07 Thousand CAD | -6285.977% |
Gemina Laboratories Ltd. | 1.45 Million CAD | -1658.765% |
Glow Lifetech Corp. | 1.91 Million CAD | -1238.864% |
Lexston Life Sciences Corp. | 750.94 Thousand CAD | -3310.709% |
Pharmala Biotech Holdings Inc. | 2.41 Million CAD | -961.649% |
Doseology Sciences Inc. | 1.1 Million CAD | -2223.713% |
MYND Life Sciences Inc. | 797.54 Thousand CAD | -3111.449% |
Nova Mentis Life Science Corp. | 31.05 Thousand CAD | -82364.619% |
PharmaTher Holdings Ltd. | 2.58 Million CAD | -888.985% |
PreveCeutical Medical Inc. | 181.51 Thousand CAD | -14010.895% |
Telescope Innovations Corp. | 3.02 Million CAD | -747.104% |